More and more patients are being diagnosed with pancreatic cysts but <1% per year will be malignant.2,3
Balancing the morbidities and mortalities associated with surgical removal of cysts with the high mortality rate of pancreatic cancer can be challenging. Understanding of the risk of malignancy for a cyst can help with decisions as to whether or not surgery is the best option for patients.
Studies have shown that up to 80% of surgeries reveal indolent cysts that didn’t necessarily require surgery.5,6
What if we could help you better predict whether a cyst will remain indolent or become malignant, providing useful information for your surveillance and surgery strategies?